American healthcare systems are overwhelmed due to the ongoing COVID-19 pandemic. Providers are managing respiratory infectious disease on a mass scale, testing their ability and agility. Remote patient monitoring and telemedicine are designed to enable healthcare systems to provide critical evaluation and care to patients outside conventional clinical settings. These methods allow patients to be monitored from afar throughout the care continuum, helping to improve outcomes while limiting the spread of respiratory infectious disease.1
Remote patient monitoring in particular has incredible potential when managing respiratory infectious disease and can be tailored to whatever phase of illness the patient is in, from asymptomatic early exposure to advanced stages and secondary infections. This can further be customized based on a patient’s unique considerations, providing focused insight into a patient’s health at any given time.
Sign up to get access to new information and webinars.
About the Author
Author Samuel Ajizian, M.D., FAAP, FCCM, CPPS is a board-certified Pediatric Intensivist with over 20 years of clinical practice in the Pediatric ICU. He received his medical degree from the University of Southern California and completed pediatric residency and Chief Residency at Children’s Hospital Los Angeles. He then entered the U.S. Air Force and served 3 years on active duty as a pediatrician and Flight Surgeon in an F-16 squadron. He then completed pediatric critical care fellowship at LeBonheur Children’s Hospital, University of Tennessee.
Dr. Ajizian joined Medtronic in 2015 in his first role as Vice President, Medical Affairs for the Patient Monitoring and Recovery business unit. In 2018, he assumed direction of the MITG Medical Safety Office. In 2020, Dr. Ajizian became interim director of the MITG Scientific Communications team. He currently oversees the production of key compliance-related deliverables including Clinical Evaluation Reports.